bg
S

Spero Therapeutics (SPRO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Spero Therapeutics (SPRO)

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil ... Read more

  • USD1.42
  • USD1.45
  • USD1.41
  • USD2.00
  • -18.00%
  • 104M
  • 110.04k
  • 236.27k
  • 75M
  • 0.99
  • -15.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.